Pharming Boosts Stake in Abliva to 92.7%
Deal News | Feb 20, 2025 | Globenewswire
Pharming Technologies B.V., a wholly-owned subsidiary of Pharming Group N.V., has announced the expansion of its stake in Abliva AB to 92.7% following a cash offer made to Abliva's shareholders. The offer, priced at SEK 0.45 per share, was declared unconditional on February 7, 2025. Pharming plans to initiate a compulsory acquisition procedure for the remaining shares and seek to delist Abliva from Nasdaq Stockholm. Legal advisement for the deal is being managed by Van Lanschot Kempen N.V., NautaDutilh N.V., and Mannheimer Swartling Advokatbyr.
Sectors
- Biopharmaceutical
- Life Sciences
Geography
- Netherlands – Pharming Group N.V. is headquartered in the Netherlands, where the company is a significant industry player.
- Sweden – Abliva AB is a Swedish company, where the acquisition and shareholding changes are taking place.
Industry
- Biopharmaceutical – Pharming Group N.V. is involved in the biopharmaceutical industry, focusing on transforming the lives of patients with rare and life-threatening diseases.
- Life Sciences – Abliva operates within the life sciences sector with a focus on bioenergetics, making it relevant in this industry classification.
Financials
- SEK 0.45 per share – The cash offer price per share offered by Pharming to the shareholders of Abliva.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Pharming Group N.V. | Bidding Company | Company | A global biopharmaceutical company dedicated to developing and commercializing protein replacement therapies. |
| Abliva AB | Target Company | Company | A Swedish public company focused on developing novel medicines for primary mitochondrial diseases. |
| Van Lanschot Kempen N.V. | Financial Advisor | Company | Provides financial advisory services to Pharming in connection with the offer. |
| NautaDutilh N.V. | Legal Advisor | Company | A law firm providing legal advisory services to Pharming. |
| Mannheimer Swartling Advokatbyr | Legal Advisor | Company | A law firm advising Pharming on legal matters concerning the acquisition. |